Siemens Healthineers (OTCMKTS:SMMNY) Trading Up 2.2% – Here’s Why

Siemens Healthineers AG (OTCMKTS:SMMNY) shares traded up 2.2% on Monday . The stock traded as high as $21.57 and last traded at $21.36. 206,438 shares traded hands during trading, an increase of 32% from the average session volume of 156,121 shares. The stock had previously closed at $20.91.

Analyst Ratings Changes

SMMNY has been the subject of a number of analyst reports. Citigroup restated a “buy” rating on shares of Siemens Healthineers in a research report on Friday, January 23rd. Zacks Research raised shares of Siemens Healthineers from a “strong sell” rating to a “hold” rating in a report on Monday, January 12th. Deutsche Bank Aktiengesellschaft downgraded shares of Siemens Healthineers from a “buy” rating to a “hold” rating in a report on Thursday, December 4th. Sanford C. Bernstein raised shares of Siemens Healthineers to a “strong-buy” rating in a report on Tuesday, January 13th. Finally, Royal Bank Of Canada initiated coverage on Siemens Healthineers in a research report on Wednesday, December 17th. They issued a “moderate buy” rating on the stock. Three analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Siemens Healthineers Stock Up 2.2%

The stock’s 50 day simple moving average is $24.35 and its 200 day simple moving average is $25.80.

Siemens Healthineers Company Profile

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.